Jennifer Meade is President of Aldevron, a leading custom manufacturer for genomic medicines. She leads the company’s strategy to support cell and gene therapy pioneers from research through commercial supply, helping build the manufacturing foundation behind some of the most advanced genetic medicines in development. Under her leadership, Aldevron continues to expand its capabilities across plasmid DNA, RNA, enzymes, and proteins to accelerate real‑world patient impact.